Papua New Guinea vs South-East Asia (WHO region): Hepatitis B surface antigen (HBsAg) prevalence

Papua New Guinea
2.5%
in 2024
South-East Asia (WHO region)
0.2%
in 2024
Papua New Guinea rank
10th
South-East Asia (WHO region) rank
8th

Hepatitis B surface antigen (HBsAg) prevalence over time

  • Papua New Guinea
  • South-East Asia (WHO region)
00.511.522.5201520192024

How they compare

Papua New Guinea currently reports 2.5% against 0.2% in South-East Asia (WHO region), a difference of 2.3%.

That makes Papua New Guinea's figure about 12.5 times South-East Asia (WHO region)'s.

Across all 10 years both countries report, Papua New Guinea has been ahead every year.

Papua New Guinea ranks 10th and South-East Asia (WHO region) ranks 8th of 194 countries.

Papua New Guinea has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Papua New Guinea South-East Asia (WHO region) Difference Ahead
2010s 2.0% 0.4% 1.5% Papua New Guinea
2020s 2.4% 0.3% 2.2% Papua New Guinea

Averages of every year both report within each decade.

Frequently asked questions

Which has higher hepatitis b surface antigen (hbsag) prevalence, Papua New Guinea or South-East Asia (WHO region)?
Papua New Guinea, at 2.5% against 0.2% in South-East Asia (WHO region) as of 2024.
What is the difference in hepatitis b surface antigen (hbsag) prevalence between Papua New Guinea and South-East Asia (WHO region)?
2.3%, with Papua New Guinea ahead.
How many years of comparable data are there for Papua New Guinea and South-East Asia (WHO region)?
10 years are reported by both, from 2015 to 2024.
How do Papua New Guinea and South-East Asia (WHO region) rank globally for hepatitis b surface antigen (hbsag) prevalence?
Papua New Guinea ranks 10th and South-East Asia (WHO region) ranks 8th of 194 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Papua New Guinea vs South-East Asia (WHO region): Hepatitis B surface antigen (HBsAg) prevalence. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 September 2026, from https://health.statizoid.com/compare/hepatitis-b-surface-antigen-hbsag-prevalence-percent/papua-new-guinea/south-east-asia-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/hepatitis-b-surface-antigen-hbsag-prevalence-percent/papua-new-guinea/south-east-asia-who-region/">Papua New Guinea vs South-East Asia (WHO region): Hepatitis B surface antigen (HBsAg) prevalence</a> — Statizoid

About this data

Indicator
Hepatitis B surface antigen (HBsAg) prevalence (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
209 places, 2,090 data points, 2015–2024
Last refreshed